Ashley Aughenbaugh, MD
Obstetrics & Gynecology · Hot Springs, ARNPI 1669913091
Payments from drug & device makers
Across 117 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$289
- Astellas Pharma US Inc$287
- AbbVie$205
- Sumitomo Pharma America, Inc.$182
- Myovant Sciences Inc.$168
- Pfizer$152
- plus $955 from 16 others
What the payments were for
- Food & beverage$2,14096%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 18 | $289 |
| Astellas Pharma US Inc | 9 | $287 |
| AbbVie | 11 | $205 |
| Sumitomo Pharma America, Inc. | 11 | $182 |
| Myovant Sciences Inc. | 10 | $168 |
| Pfizer | 13 | $152 |
| Bayer | 7 | $143 |
| Organon | 7 | $127 |
| Biogen | 5 | $111 |
| Evofem Biosciences, Inc. | 6 | $95 |
| Minerva Surgical, Inc | 6 | $86 |
| Intuitive Surgical | 1 | $72 |
| Davol Inc. | 1 | $71 |
| Shield Therapeutics Inc | 3 | $57 |
| Conmed Corporation | 1 | $44 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Millicent US Inc | 1 | $22 |
| Coloplast | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Urovant Sciences Inc | 1 | $19 |
| Merck | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
How this compares
$2,239 in reported general payments places this provider in the 60th percentile of 272 obstetrics & gynecology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 62 | $3,569 |
| Clobetasol Propionate | 13 | $587 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Hot Springs
- Laura HollenbachHot Springs$9K
- Amy GordonHot Springs$7K
- Nathan LiversLittle Rock$1.5M
- James CittySearcy$157K
- Michael CopeLittle Rock$147K
- Jeanmarie HouseholderFort Smith$140K
- Timothy BellFort Smith$53K
- Paige PartridgeJohnson$50K
- Nirvana ManningLittle Rock$47K
- Christopher TaylorHarrison$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.